Achaogen Stock Predictions

Buy AKAO

*Your capital is at risk

$0.102

+0 (+0%)

At Close: Dec 02, 2020

Currently predicting for Mon, 8 Jun 2026

AKAO Prediction Chart

AKAO Predictions History

Latest community submissions for AKAO.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Apr 5, 2019	$0.535 -0.58%	$0.540	V	99.07%	1
Gp Merchant @Gp.98898	Apr 5, 2019	$0.520 -3.36%	$0.540	V	96.30%	0
PumpTheseNumbers Pro	Apr 4, 2019	$0.506 -2.69%	$0.520	X	97.31%	0
JS Pro	Aug 10, 2018	$6.17 -0.64%	$6.21	X	99.40%	3
Andrei.Vorobev.8704	Jun 26, 2017	$20.87 -7.45%	$22.55	X	92.50%	0
JS Pro	May 24, 2017	$26.37 +11.50%	$23.65	X	88.50%	0
JuanC Villegas Pro	May 24, 2017	$26.41 +11.67%	$23.65	X	88.30%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AKAO with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ACHAOGEN

Achaogen, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antibacterials to treat multi-drug resistant (MDR) gram-negative infections in the United States. The company is principally developing plazomicin, which is in Phase III clinical trial for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. It is also involved in the resear...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	4.09%	May 06
GLBE $31.61	1.65%	May 05
SAP $172.39	7.18%	May 05
FIZZ $34.11	7.04%	May 01
ADBE $243.57	3.23%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by